Related Experiment Videos
Complement allotypes in familial and sporadic Alzheimer's disease
1Department of Neurology, Westmead Hospital, New South Wales, Australia.
Journal of Neurology
|September 1, 1991
Summary
This study investigated complement allotypes and Alzheimer's disease (AD). Findings show no association between complement C4 alleles and sporadic or familial AD, suggesting complement genes do not play a significant role in AD pathogenesis.
Area of Science:
- Immunogenetics
- Neurodegenerative Diseases
Background:
- Conflicting findings exist regarding the association between complement allotypes and Alzheimer's disease (AD).
- The complement system, particularly C4 allotypes, has been implicated in AD pathogenesis, but evidence remains inconclusive.
Purpose of the Study:
- To resolve conflicting reports on the association between complement allotypes and Alzheimer's disease (AD).
- To investigate the role of C4 phenotypes in the pathogenesis of both sporadic and familial AD.
Main Methods:
- Analysis of C4 phenotypes in 33 patients with sporadic Alzheimer's disease.
- Examination of C4 phenotypes in one family with a history of familial Alzheimer's disease.
Main Results:
- No significant association was found between complement C4 alleles and familial or sporadic Alzheimer's disease.
- A familial case exhibited the absence of the C4 null allele (C4BQ0), but this did not indicate a broader association.
- The C4B2 allele was not found to be a reliable marker for Alzheimer's disease.
Conclusions:
- The study data do not support a role for complement genes, specifically C4 allotypes, in the pathogenesis of Alzheimer's disease.
- The C4B2 allele should not be considered a diagnostic marker for Alzheimer's disease based on these findings.